It looks like you are coming from United States, but the current site you have selected to visit is India. Do you want to change sites?

Yes, please. No. Keep me on the current site.

Xylem Reports Third Quarter 2020 Results

October 29, 2020
  • Reported net income of $37 million or $0.20 per share; adjusted net income of $114 million or $0.62 per share
  • Revenue declined 6% on a reported basis, and 7% organically, impacted by COVID-19
  • Strong operating margin performance of 6% and 13% on a reported and adjusted basis, respectively, from disciplined execution on productivity and cost actions
  • Free cash flow of $234 million, up 18%, and operating cash flow of $275 million, up 12%

RYE BROOK, N.Y.--(BUSINESS WIRE)-- Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, today reported third quarter 2020 net income of $37 million, or $0.20 per share. Excluding the impact of restructuring, realignment and special charges, the Company delivered adjusted net income of $114 million or $0.62 per share in the quarter.

Third quarter revenue was $1.2 billion, down 6 percent on a reported basis and 7 percent organically, declining less than previously expected, primarily driven by the resilience of the wastewater utility business and healthy residential demand. Orders were down 7 percent on a reported basis and 8 percent, organically. Reported operating margin in the quarter was 6 percent, up 520 basis points versus the prior year. Adjusted operating margin was 13.0 percent, down 210 basis points compared to the prior year. The decline was driven largely by the pandemic’s impact on volume in the quarter.

Xylem generated $275 million of operating cash flow and $234 million of free cash flow in the quarter, representing a conversion of 215%, driven by discipline on capital spending and working capital, as well as favourable timing of interest and tax payments. The Company’s liquidity remains strong, at approximately $2.4 billion, including cash and committed credit facilities.

“Our team delivered operational performance exceeding expectations on both the top line and bottom line,” said Patrick Decker, Xylem’s president and CEO. “Our supply chain continues to be robust, we’re maintaining discipline on cost and capital, and cash generation is healthy. Overall, we’re executing with focus and purpose to make sure our customers can continue delivering essential services to their communities.”

“Despite continuing macro uncertainty, we are serving end-markets that showed signs of increasing stability through the quarter,” continued Decker. “China returned to pre-pandemic growth, Europe grew modestly, and the US, while still lagging other regions, improved sequentially in the quarter. We continue to set strong commercial pace as utilities accelerate interest in transformational technologies that increase operational and financial resilience. Physical distancing is delaying some project revenues dependent on field-work in the short term, and we continue to closely monitor COVID-19 developments. We are well-positioned irrespective of how the pandemic plays out, and set to emerge in an even stronger position.”

Outlook

Xylem expects fourth quarter organic revenue declines in the range of 6 to 8 percent and adjusted operating margin in the range of 13.0 percent to 13.5 percent. Full-year free cash flow conversion is anticipated to be greater than 100%.

Third Quarter Segment Results

Water Infrastructure

Xylem’s Water Infrastructure segment consists of its portfolio of businesses serving wastewater transport and treatment, clean water delivery, and dewatering.

  • Third quarter 2020 revenue was $524 million, down 2 percent organically, and down 1 percent as reported, compared with third quarter 2019. Resilience in wastewater transport and treatment spending continued as the utilities end market returned to mid-single digit growth. The industrial end market declined mid-teens driven by softness in dewatering applications.
  • Third quarter reported operating income for the segment was $89 million. Adjusted operating income for the segment, which excludes $8 million of restructuring and realignment costs, was $97 million. Reported operating margin for the segment was 17.0 percent, down 130 basis points versus prior year. Adjusted operating margin of 18.5 percent was down 110 basis points versus prior year from lower sales volume, unfavourable mix and higher inflation partially offset by productivity benefits and cost reductions.

Applied Water

Xylem’s Applied Water segment consists of its portfolio of businesses in industrial, commercial building, and residential applications.

  • Third quarter 2020 revenue was $364 million, a 4 percent decline organically year-over-year, a 3 percent decline as reported. Modest growth from demand in the residential end market was offset by softness in industrial and commercial end markets.
  • Third quarter reported operating income for the segment was $56 million and adjusted operating income, which excludes $2 million of restructuring and realignment costs, was $58 million. The segment’s reported operating margin was 15.4 percent, down 80 basis points versus prior year, and adjusted operating margin was 15.9 percent, down 110 basis points versus prior year. Lower sales volume and inflation were partially offset by productivity gains.

Measurement & Control Solutions

Xylem’s Measurement & Control Solutions segment consists of its portfolio of businesses in smart metering, network technologies, advanced infrastructure analytics and analytic instrumentation.

  • Third quarter 2020 revenue was $332 million, down 15 percent organically and as reported, driven primarily by project deployment delays and site access restrictions related to COVID-19 in our metrology and pipeline assessment services businesses.
  • Reported operating income for the segment was negative $62 million, and adjusted operating income was $12 million, which excludes $5 million of restructuring and realignment costs and $69 million of special charges, including an accounting charge against goodwill in the pipeline assessment services business. Reported operating margin was up 16.3 percent versus prior year, at negative 18.7 percent. The segment’s adjusted EBITDA margin was 14.8%, down 450 bps from the prior year, driven by short-term volume declines and inflation, partially offset by productivity.

Supplemental information on Xylem’s third quarter 2020 earnings and reconciliations for certain non-GAAP items are posted at www.xylem.com/investors.

About Xylem

Xylem (XYL) is a leading global water technology company committed to solving critical water and infrastructure challenges with technological innovation. Our more than 16,000 diverse employees delivered revenue of $5.25 billion in 2019. We are creating a more sustainable world by enabling our customers to optimize water and resource management, and helping communities in more than 150 countries become water-secure. Join us at www.xylem.com.

Forward-Looking Statements

This press release contains information that may constitute “forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Generally, the words “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” "contemplate," "predict," “forecast,” “believe,” “target,” “will,” “could,” “would,” “should,” "potential," "may" and similar expressions may, but are not necessary to, identify forward-looking statements. By their nature, forward-looking statements address uncertain matters and include any statements that: are not historical, such as statements about the Company’s capitalization, restructuring and realignment plans, and future strategic plans; describe the Company’s business strategy, outlook, objectives, plans, intentions or goals; or address operating or financial performance, events or developments that we expect or anticipate will occur in the future - including statements relating to orders, revenues, operating margins and earnings per share growth, and expressing general views about future operating results. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from those expressed or implied in, or reasonably inferred from, such statements. The novel coronavirus (“COVID-19”) pandemic is and may continue to amplify many of these risks and uncertainties.

Factors that could cause results to differ materially from those anticipated include: overall economic and business conditions; the COVID-19 pandemic’s uncertain magnitude, duration, geographic reach and impact on the global economy; the current and future impact of the COVID-19 pandemic on our business, growth, projections, financial condition, operations, cash flows, and liquidity, including from adverse economic conditions on our performance or customer markets caused by the COVID-19 pandemic; actual or potential other epidemics, pandemics or global health crises; geopolitical and other risks associated with our international operations that could affect customer markets and our business, such as military actions, protectionism, economic sanctions or trade barriers, including tariffs and embargoes, and non-compliance with laws or regulations, including those pertaining to foreign corrupt practices, data privacy, export and import and competition; potential for unexpected cancellations or delays of customer orders in our reported backlog; fluctuations in foreign currency exchange rates; disruption, competition and pricing pressures in the markets we serve; industrial, governmental and private sector spending; the strength of housing and related markets; weather conditions; ability to retain and attract talent and key members of management; our relationship with and the performance of our supply chain, including channel partners; our ability to successfully identify, complete and integrate acquisitions; our ability to borrow or refinance our existing indebtedness; availability of liquidity sufficient to meet our needs; uncertainty from the expected discontinuance of LIBOR and transition to another interest rate benchmark; changes in the value of goodwill or intangible assets; uncertainty related to restructuring and realignment actions and related charges and savings, including with respect to the amount and timing of estimated costs and savings, the timing of or delays in implementing actions, and our ability to realize all of the anticipated cost savings, all of which are subject to change as the Company makes decisions and refines plans and estimates over time; management and employee distraction resulting from restructuring actions; timing delays in implementing strategic initiatives; our ability to continue strategic investments for growth; risks relating to products, including defects, security, liability and recalls; governmental or regulatory claims or investigations; cybersecurity attacks, breaches or other disruptions of information technology systems on which we rely, or on our products; our sustainability initiatives; the use of proceeds from our green bond offering, including failure to appropriately allocate the net proceeds or meet the investment requirements of certain environmentally-focused investors; litigation and contingent liabilities; and other factors set forth under “Item 1A. Risk Factors” in our Annual Report on Form10-K for the year ended December 31, 2019, "Item 1A. Risk Factors" in the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2020 and in subsequent filings we have made or may make with the Securities and Exchange Commission. All forward-looking statements made herein are based on information currently available to the Company as of the date of this press release. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

 

XYLEM INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED INCOME STATEMENTS (Unaudited)

(in millions, except per share data)

 

 

Three Months

 

Nine Months

For the periods ended September 30,

2020

 

2019

 

2020

 

2019

Revenue

$

1,220

 

 

$

1,296

 

 

$

3,503

 

 

$

3,878

 

Cost of revenue

759

 

 

787

 

 

2,199

 

 

2,369

 

Gross profit

461

 

 

509

 

 

1,304

 

 

1,509

 

Selling, general and administrative expenses

266

 

 

273

 

 

851

 

 

870

 

Research and development expenses

45

 

 

44

 

 

138

 

 

142

 

Restructuring and asset impairment charges

19

 

 

33

 

 

69

 

 

58

 

Goodwill impairment charge

58

 

 

148

 

 

58

 

 

148

 

Operating income

73

 

 

11

 

 

188

 

 

291

 

Interest expense

22

 

 

16

 

 

56

 

 

52

 

Other non-operating expense, net

(1

)

 

(7

)

 

(5

)

 

(2

)

Gain from sale of business

 

 

 

 

 

 

1

 

Income (loss) before taxes

50

 

 

(12

)

 

127

 

 

238

 

Income tax expense (benefit)

13

 

 

(77

)

 

21

 

 

(45

)

Net income

$

37

 

 

$

65

 

 

$

106

 

 

$

283

 

Earnings per share:

 

 

 

 

 

 

 

Basic

$

0.20

 

 

$

0.36

 

 

$

0.59

 

 

$

1.57

 

Diluted

$

0.20

 

 

$

0.36

 

 

$

0.58

 

 

$

1.56

 

Weighted average number of shares:

 

 

 

 

 

 

 

Basic

180.0

 

 

180.1

 

 

180.1

 

 

179.9

 

Diluted

181.0

 

 

181.2

 

 

181.0

 

 

181.2

 

 

XYLEM INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)

 

(in millions, except per share amounts)

September 30,
2020

 

December 31,
2019

 

 

 

 

ASSETS

 

 

 

Current assets:

 

 

 

Cash and cash equivalents

$

1,402

 

 

$

724

 

Short-term investments

200

 

 

 

Receivables, less allowances for discounts, returns and doubtful accounts of $40 and $35 in 2020 and 2019, respectively

968

 

 

1,036

 

Inventories

582

 

 

539

 

Prepaid and other current assets

159

 

 

151

 

Total current assets

3,311

 

 

2,450

 

Property, plant and equipment, net

633

 

 

658

 

Goodwill

2,795

 

 

2,839

 

Other intangible assets, net

1,090

 

 

1,174

 

Other non-current assets

619

 

 

589

 

Total assets

$

8,448

 

 

$

7,710

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

 

 

 

Current liabilities:

 

 

 

Accounts payable

$

495

 

 

$

597

 

Accrued and other current liabilities

745

 

 

628

 

Short-term borrowings and current maturities of long-term debt

40

 

 

276

 

Total current liabilities

1,280

 

 

1,501

 

Long-term debt

3,053

 

 

2,040

 

Accrued postretirement benefits

455

 

 

445

 

Deferred income tax liabilities

283

 

 

310

 

Other non-current accrued liabilities

502

 

 

447

 

Total liabilities

5,573

 

 

4,743

 

 

 

 

 

Stockholders’ equity:

 

 

 

Common Stock – par value $0.01 per share:

 

 

 

Authorized 750.0 shares, issued 194.6 shares and 193.9 shares in 2020 and 2019, respectively

2

 

 

2

 

Capital in excess of par value

2,021

 

 

1,991

 

Retained earnings

1,828

 

 

1,866

 

Treasury stock – at cost 14.5 shares and 13.7 shares in 2020 and 2019, respectively

(588

)

 

(527

)

Accumulated other comprehensive loss

(396

)

 

(375

)

Total stockholders’ equity

2,867

 

 

2,957

 

Non-controlling interests

8

 

 

10

 

Total equity

2,875

 

 

2,967

 

Total liabilities and stockholders’ equity

$

8,448

 

 

$

7,710

 

 

XYLEM INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

(in millions)

 

For the nine months ended September 30,

2020

 

2019

Operating Activities

 

 

 

Net income

$

106

 

 

$

283

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

Depreciation

88

 

 

88

 

Amortization

101

 

 

104

 

Share-based compensation

19

 

 

23

 

Restructuring and asset impairment charges

69

 

 

58

 

Goodwill impairment charge

58

 

 

148

 

Gain from sale of business

 

 

(1

)

Other, net

33

 

 

7

 

Payments for restructuring

(25

)

 

(21

)

Changes in assets and liabilities (net of acquisitions):

 

 

 

Changes in receivables

43

 

 

(73

)

Changes in inventories

(48

)

 

(2

)

Changes in accounts payable

(91

)

 

(30

)

Changes in accrued taxes

(5

)

 

(140

)

Other, net

106

 

 

7

 

Net Cash – Operating activities

454

 

 

451

 

Investing Activities

 

 

 

Capital expenditures

(136

)

 

(175

)

Acquisitions of businesses, net of cash acquired

 

 

(18

)

Proceeds from sale of business

 

 

(2

)

Proceeds from the sale of property, plant and equipment

1

 

 

 

Cash received from investments

 

 

3

 

Cash paid for investments

(200

)

 

 

Other, net

9

 

 

7

 

Net Cash – Investing activities

(326

)

 

(185

)

Financing Activities

 

 

 

Short-term debt issued, net

359

 

 

317

 

Short-term debt repaid

(600

)

 

(254

)

Long-term debt issued, net

985

 

 

 

Repurchase of common stock

(61

)

 

(39

)

Proceeds from exercise of employee stock options

10

 

 

10

 

Dividends paid

(142

)

 

(131

)

Other, net

(1

)

 

(2

)

Net Cash – Financing activities

550

 

 

(99

)

Effect of exchange rate changes on cash

 

 

(10

)

Net change in cash and cash equivalents

678

 

 

157

 

Cash and cash equivalents at beginning of year

724

 

 

296

 

Cash and cash equivalents at end of period

$

1,402

 

 

$

453

 

Supplemental disclosure of cash flow information:

 

 

 

Cash paid during the period for:

 

 

 

Interest

$

46

 

 

$

46

 

Income taxes (net of refunds received)

$

27

 

 

$

94

 

 

Xylem Inc. Non-GAAP Measures

Management reviews key performance indicators including revenue, gross margins, segment operating income and margins, orders growth, working capital and backlog, among others. In addition, we consider certain non-GAAP (or "adjusted") measures to be useful to management and investors evaluating our operating performance for the periods presented, and to provide a tool for evaluating our ongoing operations, liquidity and management of assets. This information can assist investors in assessing our financial performance and measures our ability to generate capital for deployment among competing strategic alternatives and initiatives, including but not limited to, dividends, acquisitions, share repurchases and debt repayment. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort. These adjusted metrics are consistent with how management views our business and are used to make financial, operating and planning decisions. These metrics, however, are not measures of financial performance under GAAP and should not be considered a substitute for revenue, operating income, net income, earnings per share (basic and diluted) or net cash from operating activities as determined in accordance with GAAP. We consider the following items to represent the non-GAAP measures we consider to be key performance indicators, as well as the related reconciling items to the most directly comparable measure calculated and presented in accordance with GAAP. The non-GAAP measures may not be comparable to similarly titled measures reported by other companies.

“Organic revenue and Organic orders” defined as revenue and orders, respectively, excluding the impact of fluctuations in foreign currency translation and contributions from acquisitions and divestitures. Divestitures include sales of insignificant portions of our business that did not meet the criteria for classification as a discontinued operation. The period-over-period change resulting from foreign currency translation impacts is determined by translating current period and prior period activity using the same currency conversion rate.

“Constant currency” defined as financial results adjusted for foreign currency translation impacts by translating current period and prior period activity using the same currency conversion rate. This approach is used for countries whose functional currency is not the U.S. dollar.

“EBITDA” defined as earnings before interest, taxes, depreciation and amortization expense. “Adjusted EBITDA” reflects the adjustment to EBITDA to exclude share-based compensation charges, restructuring and realignment costs, gain or loss from sale of businesses and special charges.

Adjusted Operating Income, Adjusted Segment Operating Income, Adjusted Net Income and “Adjusted EPS” defined as operating income, segment operating income, net income and earnings per share, adjusted to exclude restructuring and realignment costs, gain or loss from sale of businesses, special charges and tax-related special items, as applicable.

Adjusted Operating Margin and Adjusted Segment Operating Margin defined as adjusted operating income and adjusted segment operating income divided by total revenue and segment revenue, respectively.

“Free Cash Flow” defined as net cash from operating activities, as reported in the Statement of Cash Flow, less capital expenditures, and Free Cash Flow Conversiondefined as Free Cash Flow divided by net income, excluding the gain on sale of businesses, non-cash impairment charges and siginificant deferred tax items. Our definitions of "free cash flow" and "free cash flow conversion" does not consider certain non-discretionary cash payments, such as debt.

“Realignment costs” defined as costs not included in restructuring costs that are incurred as part of actions taken to reposition our business, including items such as professional fees, severance, relocation, travel, facility set-up and other costs.

“Special charges defined as costs incurred by the Company, such as acquisition and integration related costs, non-cash impairment charges and both operating and non-operating adjustments for pension costs.

“Tax-related special items defined as tax items, such as tax return versus tax provision adjustments, tax exam impacts, tax law change impacts, excess tax benefits/losses and other discrete tax adjustments.

Xylem Inc. Non-GAAP Reconciliation
Reported vs. Organic & Constant Currency Orders
($ Millions)
 
(As Reported - GAAP) (As Adjusted - Organic)

Constant Currency

(A) (B) (C) (D) (E) = B+C+D (F) = E/A (G) = (E - C) / A
 
Change % Change

Acquisitions /

Change % Change
Orders Orders 2020 v. 2019 2020 v. 2019 Divestitures FX Impact Adj. 2020 v. 2019 Adj. 2020 v. 2019

2020

2019

Nine Months Ended September 30
 
Xylem Inc.

3,739

4,053

(314

)

(8

%)

-

49

 

(265

)

(7

%)

(7

%)

 
Water Infrastructure

1,670

1,704

(34

)

(2

%)

-

38

 

4

 

0

%

0

%

Applied Water

1,073

1,169

(96

)

(8

%)

-

7

 

(89

)

(8

%)

(8

%)

Measurement & Control Solutions

996

1,180

(184

)

(16

%)

-

4

 

(180

)

(15

%)

(15

%)

 
Quarter Ended September 30
 
Xylem Inc.

1,246

1,346

(100

)

(7

%)

-

(10

)

(110

)

(8

%)

(8

%)

 
Water Infrastructure

558

586

(28

)

(5

%)

-

(4

)

(32

)

(5

%)

(5

%)

Applied Water

375

376

(1

)

(0

%)

-

(3

)

(4

)

(1

%)

(1

%)

Measurement & Control Solutions

313

384

(71

)

(18

%)

-

(3

)

(74

)

(19

%)

(19

%)

 
Quarter Ended June 30
 
Xylem Inc.

1,232

1,392

(160

)

(11

%)

-

36

 

(124

)

(9

%)

(9

%)

 
Water Infrastructure

598

586

12

 

2

%

-

27

 

39

 

7

%

7

%

Applied Water

326

399

(73

)

(18

%)

-

6

 

(67

)

(17

%)

(17

%)

Measurement & Control Solutions

308

407

(99

)

(24

%)

-

3

 

(96

)

(24

%)

(24

%)

 
Quarter Ended March 31
 
Xylem Inc.

1,261

1,315

(54

)

(4

%)

-

23

 

(31

)

(2

%)

(2

%)

 
Water Infrastructure

514

532

(18

)

(3

%)

-

15

 

(3

)

(1

%)

(1

%)

Applied Water

372

394

(22

)

(6

%)

-

4

 

(18

)

(5

%)

(5

%)

Measurement & Control Solutions

375

389

(14

)

(4

%)

-

4

 

(10

)

(3

%)

(3

%)

 
Xylem Inc. Non-GAAP Reconciliation
Reported vs. Organic & Constant Currency Revenue
($ Millions)
 
(As Reported - GAAP) (As Adjusted - Organic)

Constant Currency

(A) (B) (C) (D) (E) = B+C+D (F) = E/A (G) = (E - C) / A
 
Change % Change

Acquisitions /

Change % Change
Revenue Revenue 2020 v. 2019 2020 v. 2019 Divestitures FX Impact Adj. 2020 v. 2019 Adj. 2020 v. 2019

2020

2019

Nine Months Ended September 30
 
Xylem Inc.

3,503

3,878

(375

)

(10

%)

-

35

 

(340

)

(9

%)

(9

%)

 
Water Infrastructure

1,463

1,574

(111

)

(7

%)

-

24

 

(87

)

(6

%)

(6

%)

Applied Water

1,039

1,149

(110

)

(10

%)

-

6

 

(104

)

(9

%)

(9

%)

Measurement & Control Solutions

1,001

1,155

(154

)

(13

%)

-

5

 

(149

)

(13

%)

(13

%)

 
Quarter Ended September 30
 
Xylem Inc.

1,220

1,296

(76

)

(6

%)

-

(9

)

(85

)

(7

%)

(7

%)

 
Water Infrastructure

524

531

(7

)

(1

%)

-

(4

)

(11

)

(2

%)

(2

%)

Applied Water

364

376

(12

)

(3

%)

-

(3

)

(15

)

(4

%)

(4

%)

Measurement & Control Solutions

332

389

(57

)

(15

%)

-

(2

)

(59

)

(15

%)

(15

%)

 
Quarter Ended June 30
 
Xylem Inc.

1,160

1,345

(185

)

(14

%)

-

25

 

(160

)

(12

%)

(12

%)

 
Water Infrastructure

501

561

(60

)

(11

%)

-

16

 

(44

)

(8

%)

(8

%)

Applied Water

337

394

(57

)

(14

%)

-

6

 

(51

)

(13

%)

(13

%)

Measurement & Control Solutions

322

390

(68

)

(17

%)

-

3

 

(65

)

(17

%)

(17

%)

 
Quarter Ended March 31
 
Xylem Inc.

1,123

1,237

(114

)

(9

%)

-

19

 

(95

)

(8

%)

(8

%)

 
Water Infrastructure

438

482

(44

)

(9

%)

-

12

 

(32

)

(7

%)

(7

%)

Applied Water

338

379

(41

)

(11

%)

-

3

 

(38

)

(10

%)

(10

%)

Measurement & Control Solutions

347

376

(29

)

(8

%)

-

4

 

(25

)

(7

%)

(7

%)

 
Xylem Inc. Non-GAAP Reconciliation
Adjusted Operating Income
($ Millions)
 
 
 

Q1

 

Q2

 

Q3

 

YTD

2020

2019

 

2020

2019

 

2020

2019

 

2020

2019

Total Revenue
• Total Xylem

1,123

 

1,237

 

1,160

 

1,345

 

1,220

 

1,296

 

3,503

 

3,878

 

• Water Infrastructure

438

 

482

 

501

 

561

 

-

524

 

531

 

1,463

 

1,574

 

• Applied Water

338

 

379

 

337

 

394

 

-

364

 

376

 

1,039

 

1,149

 

• Measurement & Control Solutions

347

 

376

 

322

 

390

 

332

 

389

 

1,001

 

1,155

 

 
Operating Income
• Total Xylem

61

 

109

 

54

 

171

 

73

 

11

 

188

 

291

 

• Water Infrastructure

39

 

51

 

73

 

98

 

-

89

 

97

 

201

 

246

 

• Applied Water

47

 

56

 

41

 

62

 

-

56

 

61

 

144

 

179

 

• Measurement & Control Solutions

(12

)

16

 

(46

)

26

 

(62

)

(136

)

(120

)

(94

)

• Total Segments

74

 

123

 

68

 

186

 

83

 

22

 

225

 

331

 

 
Operating Margin
• Total Xylem

5.4

%

8.8

%

4.7

%

12.7

%

6.0

%

0.8

%

5.4

%

7.5

%

• Water Infrastructure

8.9

%

10.6

%

14.6

%

17.5

%

17.0

%

18.3

%

13.7

%

15.6

%

• Applied Water

13.9

%

14.8

%

12.2

%

15.7

%

15.4

%

16.2

%

13.9

%

15.6

%

• Measurement & Control Solutions

(3.5

%)

4.3

%

(14.3

%)

6.7

%

(18.7

%)

(35.0

%)

(12.0

%)

(8.1

%)

• Total Segments

6.6

%

9.9

%

5.9

%

13.8

%

6.8

%

1.7

%

6.4

%

8.5

%

 
Special Charges
• Total Xylem

-

 

4

 

11

 

-

 

70

 

155

 

81

 

159

 

• Water Infrastructure

-

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

• Applied Water

-

 

-

 

-

 

-

 

-

 

-

 

-

 

-

 

• Measurement & Control Solutions

-

 

4

 

10

 

-

 

69

 

155

 

79

 

159

 

• Total Segments

-

 

4

 

10

 

-

 

69

 

155

 

79

 

159

 

 
Restructuring & Realignment Costs
• Total Xylem

9

 

20

 

43

 

21

 

15

 

30

 

67

 

71

 

• Water Infrastructure

5

 

9

 

8

 

9

 

8

 

7

 

21

 

25

 

• Applied Water

2

 

3

 

4

 

4

 

2

 

3

 

8

 

10

 

• Measurement & Control Solutions

2

 

8

 

31

 

8

 

5

 

20

 

38

 

36

 

• Total Segments

9

 

20

 

43

 

21

 

15

 

30

 

67

 

71

 

 
Adjusted Operating Income
• Total Xylem

70

 

133

 

108

 

192

 

158

 

196

 

336

 

521

 

• Water Infrastructure

44

 

60

 

81

 

107

 

-

97

 

104

 

222

 

271

 

• Applied Water

49

 

59

 

45

 

66

 

-

58

 

64

 

152

 

189

 

• Measurement & Control Solutions

(10

)

28

 

(5

)

34

 

-

12

 

39

 

(3

)

101

 

• Total Segments

83

 

147

 

121

 

207

 

167

 

207

 

371

 

561

 

 
Adjusted Operating Margin
• Total Xylem

6.2

%

10.8

%

9.3

%

14.3

%

13.0

%

15.1

%

9.6

%

13.4

%

• Water Infrastructure

10.0

%

12.4

%

16.2

%

19.1

%

18.5

%

19.6

%

15.2

%

17.2

%

• Applied Water

14.5

%

15.6

%

13.4

%

16.8

%

15.9

%

17.0

%

14.6

%

16.4

%

• Measurement & Control Solutions

(2.9

%)

7.4

%

(1.6

%)

8.7

%

3.6

%

10.0

%

(0.3

%)

8.7

%

• Total Segments

7.4

%

11.9

%

10.4

%

15.4

%

13.7

%

16.0

%

10.6

%

14.5

%

 
Xylem Inc. Non-GAAP Reconciliation
Adjusted Diluted EPS
($ Millions, except per share amounts)
 
 
 

Q3 2020

Q3 2019

As Reported Adjustments Adjusted As Reported Adjustments Adjusted
Total Revenue

 

1,220

 

 

-

 

 

1,220

 

 

1,296

 

 

-

 

 

1,296

 

Operating Income

 

73

 

 

85

 

a

 

158

 

 

11

 

 

185

 

a

 

196

 

Operating Margin

 

6.0

%

 

13.0

%

 

0.8

%

 

15.1

%

Interest Expense

 

(22

)

 

-

 

 

(22

)

 

(16

)

 

-

 

 

(16

)

Other Non-Operating Income (Expense)

 

(1

)

 

1

 

b

 

-

 

 

(7

)

 

11

 

b

 

4

 

Income before Taxes

 

50

 

 

86

 

 

136

 

 

(12

)

 

196

 

 

184

 

Provision for Income Taxes

 

(13

)

 

(9

)

c

 

(22

)

 

77

 

 

(112

)

c

 

(35

)

Net Income Attributable to Xylem

 

37

 

 

77

 

 

114

 

 

65

 

 

84

 

 

149

 

Diluted Shares

 

181.0

 

 

181.0

 

 

181.2

 

 

181.2

 

Diluted EPS

$

0.20

 

$

0.42

 

$

0.62

 

$

0.36

 

$

0.46

 

$

0.82

 

 
Year-over-year currency translation impact on current year diluted EPS

$

0.01

 

$

-

 

$

0.01

 

Diluted EPS at Constant Currency

$

0.19

 

$

0.42

 

$

0.61

 

 
 
 

Q3 YTD 2020

Q3 YTD 2019

As Reported Adjustments Adjusted As Reported Adjustments Adjusted
Total Revenue

 

3,503

 

 

-

 

 

3,503

 

 

3,878

 

 

-

 

 

3,878

 

Operating Income

 

188

 

 

148

 

a

 

336

 

 

291

 

 

230

 

a

 

521

 

Operating Margin

 

5.4

%

 

9.6

%

 

7.5

%

 

13.4

%

Interest Expense

 

(56

)

 

-

 

 

(56

)

 

(52

)

 

-

 

 

(52

)

Other Non-Operating Income (Expense)

 

(5

)

 

4

 

b

 

(1

)

 

(2

)

 

11

 

b

 

9

 

Gain/(Loss) From Sale of Businesses

 

-

 

 

-

 

 

-

 

 

1

 

 

(1

)

 

-

 

Income before Taxes

 

127

 

 

152

 

 

279

 

 

238

 

 

240

 

 

478

 

Provision for Income Taxes

 

(21

)

 

(29

)

c

 

(50

)

 

45

 

 

(137

)

c

 

(92

)

Net Income Attributable to Xylem

 

106

 

 

123

 

 

229

 

 

283

 

 

103

 

 

386

 

Diluted Shares

 

181.0

 

 

181.0

 

 

181.2

 

 

181.2

 

Diluted EPS

$

0.58

 

$

0.67

 

$

1.25

 

$

1.56

 

$

0.57

 

$

2.13

 

 
Year-over-year currency translation impact on current year diluted EPS

$

(0.01

)

$

-

 

$

(0.01

)

Diluted EPS at Constant Currency

$

0.59

 

$

0.67

 

$

1.26

 

a

Quarter-to-date: Restructuring & realignment costs of $15 million in 2020 and $30 million in 2019.; special charges of $70 million ($69 million of intangible asset and goodwill impairment charges and $1 million of other charges) in 2020 and $155 million of intangible asset and goodwill impairment in 2019.

Year-to-date: Restructuring & realignment costs of $67 million and $71 million in 2020 and 2019, respectively; special charges of $81 million ($79 million of intangible asset and goodwill impairment charges and $2 million of other charges) and $155 million of intangible asset and goodwill impairment and $4 million of special charges in 2019 ($1 million of acquisition related costs and $3 million of asset impairment).

b

Special non-operating charges consist of pension costs related to the UK pension plan that has been transferred to an annuity in 2020 as part of the planned buyout activities.

c

Quarter-to-date: Net tax impact on restructuring & realignment costs of $3 million and $9 million in 2020 and 2019, respectively; $6 million of tax on special charges in 2020 and $2 million in 2019; and $0 million and $101 millon of negative impact from tax related special benefit adjustments in 2020 and 2019, respectively.

Year-to-date: Net tax impact on restructuring & realignment costs of $15 million and $17 million in 2020 and 2019, respectively; $9 million and $2 million of tax impact on special charges in 2020 and 2019; and $5 million and $118 million of negative impact from tax related special benefit adjustments in 2020 and 2019, respectively.

 
Xylem Inc. Non-GAAP Reconciliation
Net Cash - Operating Activities vs. Free Cash Flow
($ Millions)
 
 

Q1

 

Q2

 

Q3

 

Year-to-Date

2020

 

2019

 

2020

 

2019

 

2020

 

2019

 

2020

 

2019

 
Net Cash - Operating Activities

$

(2

)

$

83

 

$

181

 

$

123

 

$

275

 

$

245

 

$

454

 

$

451

 

 
Capital Expenditures - PP&E

 

(32

)

 

(53

)

 

(24

)

 

(40

)

 

(24

)

 

(28

)

 

(80

)

 

(121

)

Capital Expenditures - Software

 

(19

)

 

(16

)

 

(20

)

 

(20

)

 

(17

)

 

(18

)

 

(56

)

 

(54

)

Capital Expenditures

 

(51

)

 

(69

)

 

(44

)

 

(60

)

 

(41

)

 

(46

)

 

(136

)

 

(175

)

 
Free Cash Flow

$

(53

)

$

14

 

$

137

 

$

63

 

$

234

 

$

199

 

$

318

 

$

276

 

 
Net Income

 

38

 

 

79

 

 

31

 

 

139

 

 

37

 

 

65

 

 

106

 

$

283

 

 
Gain/(Loss) from sale of businesses

 

-

 

 

1

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

1

 

 
Restructuring & Realignment Charges - non-cash impairment

 

-

 

 

-

 

 

(17

)

 

-

 

 

(3

)

 

-

 

 

(20

)

 

-

 

 
Special Charges - non-cash impairment

 

-

 

 

(3

)

 

(10

)

 

-

 

 

(69

)

 

(155

)

 

(79

)

 

(158

)

 
Significant deferred tax benefit/(charge)

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

97

 

 

-

 

 

97

 

 
Net Income, excluding gain on sale of businesses, non-cash impairment charges and significant deferred tax items

$

38

 

$

81

 

$

58

 

$

139

 

$

109

 

$

123

 

$

205

 

$

343

 

 
Operating Cash Flow Conversion

 

(5

%)

 

105

%

 

584

%

 

88

%

 

743

%

 

377

%

 

428

%

 

159

%

 
Free Cash Flow Conversion

 

(139

%)

 

17

%

 

236

%

 

45

%

 

215

%

 

162

%

 

155

%

 

80

%

 
 
Xylem Inc. Non-GAAP Reconciliation
EBITDA and Adjusted EBITDA by Quarter
Measurement & Control Solutions
($ Millions)
 

 

2020

Q1

Q2

Q3

Q4

Total

 
Pre-Tax Income

(13

)

(46

)

(62

)

(121

)

 
Interest Expense (Income), net

-

 

-

 

-

 

-

 

Depreciation

9

 

8

 

9

 

26

 

Amortization

27

 

26

 

27

 

80

 

EBITDA

23

 

(12

)

(26

)

-

 

(15

)

 
Share-based Compensation

2

 

1

 

1

 

4

 

 
Restructuring & Realignment

2

 

31

 

5

 

38

 

 
Special Charges

-

 

10

 

69

 

79

 

 
Adjusted EBITDA

27

 

30

 

49

 

-

 

106

 

 
Revenue

347

 

322

 

332

 

1,001

 

 
Adjusted EBITDA Margin

7.8

%

9.3

%

14.8

%

10.6

%

 

 

2019

Q1

Q2

Q3

Q4

Total

 
Pre-Tax Income

16

 

26

 

(137

)

28

 

(67

)

 
Interest Expense (Income), net

-

 

-

 

-

 

-

 

-

 

Depreciation

9

 

9

 

9

 

10

 

37

 

Amortization

27

 

26

 

27

 

27

 

107

 

EBITDA

52

 

61

 

(101

)

65

 

77

 

 
Share-based Compensation

1

 

2

 

1

 

1

 

5

 

 
Restructuring & Realignment

8

 

8

 

20

 

2

 

38

 

 
Loss/(Gain) from sale of business

(1

)

-

 

-

 

-

 

(1

)

 
Special Charges

4

 

-

 

155

 

-

 

159

 

 
Adjusted EBITDA

64

 

71

 

75

 

68

 

278

 

 
Revenue

376

 

390

 

389

 

376

 

1,531

 

 
Adjusted EBITDA Margin

17.0

%

18.2

%

19.3

%

18.1

%

18.2

%

 

Media
Houston Spencer +1 (914) 323-5723
houston.spencer@xyleminc.com

Investors
Matt Latino +1 (914) 323-5821
matthew.latino@xyleminc.com

Source: Xylem Inc.

Xylem